Featured
Last news
New To The Street's Esteemed Client HPB Powers Top International Bobsleigh And Skeleton Teams For The 2025/26 Season
NEW YORK CITY, NEW YORK / ACCESS Newswire / November 25, 2025 / HPB has announced its partnership with leading bobsleigh teams across Germany, Austria, Great Britain and the United States for the 2025/26 IBSF World Cup season. The collaboration unites HPB's proprietary solid-state battery technology with athletes who embody the same core values: high performance at low temperatures. This alignment, the company says, is why it is proud to continue supporting top athletes. The 2025/26 season marks the third year of HPB's multi-year sponsorships as the Olympic year approaches.
CureVac Announces Voting Results of Extraordinary General Meeting
TÜBINGEN, DE AND BOSTON, MA / ACCESS Newswire / November 25, 2025 / CureVac N.V. (Nasdaq:CVAC)(CureVac or the Company), a pioneering multinational biotech company developing a new class of transformative medicines based on messenger RNA (mRNA), today announced the voting results of its Extraordinary General Meeting (EGM).
Onco-Innovations Attends University of Alberta's 2025 Innovation Awards
VANCOUVER, BC / ACCESS Newswire / November 25, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce that it was invited to attend the University of Alberta's 2025 Innovation Awards in Edmonton, Alberta, which were held on November 21, 2025. The annual ceremony is meant to recognize outstanding research and innovation that can translate university discoveries into societal and commercial impact.
President Trump Expected to Remove Cannabis Barriers to MMJ Research and Drug Development
"We built real medicine while the industry chased loopholes," said Duane Boise, President and CEO of MMJ International Holdings. "We have a stabilized, standardized, and analytically verified cannabinoid pharmaceutical, ready for clinical trials.
Click Media Reveals Why St. Tammany Parish Law Firms Need a Hyper-Local Digital Marketing Partner
Covington-based agency outlines how localized SEO, mapping visibility, and digital reputation strategies help attorneys outperform national competitors.
Medical Care Technologies Inc. (OTC Pink:MDCE) Strengthens Foundational AI Infrastructure as Company Prepares for Next Development Milestones
MESA, ARIZONA / ACCESS Newswire / November 25, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) today confirmed that it has initiated the next stage of infrastructure preparation and early system testing to support the long-term scalability of its AI-driven health analytics platform.
Mann Eye Institute Announces Its Holiday Luxury Showcase: An Exclusive Evening of Designer Eyewear
The showcase brings together an elevated collection of high-end frames and sunglasses from some of the most sought-after luxury and designer brands. Guests can explore new arrivals, seasonal favorites, and specialty pieces that rarely make their way onto the shelves. It's an opportunity to see and shop eyewear that pairs advanced craftsmanship with the kind of flair people love showing off during holiday gatherings.
Vanderbilt Report: How Vision Wave Turned Defense Constraints Into Competitive Advantage
BRISTOL, TN / ACCESS Newswire / November 25, 2025 / VisionWave Holdings, Inc (Nasdaq:VWAV) is a public company trading on the NASDAQ building AI systems for defense platforms. What makes them noteworthy isn't the technology itself. It's where the technology actually works.
New Generation Consumer Group Provides Corporate Update as Due Diligence Advances on Spiritual Glow Acquisition
PHOENIX, AZ / ACCESS Newswire / November 25, 2025 / New Generation Consumer Group, Inc. (OTCID:NGCG) today issued a corporate update as the Company continues moving through the due diligence phase related to the proposed acquisition of a 51% controlling interest in the Spiritual Glow digital brand.
VSee Health's iDoc Division Powers Ahead: Delivering on Major Contracts and Igniting Revenue Growth!
SAN JOSE, CALIFORNIA / ACCESS Newswire / November 25, 2025 / VSee Health, Inc. (NASDAQ:VSEE), a leader in innovative telemedicine solutions, today announced exciting progress in implementing and fulfilling its previously announced contracts through its iDoc platform. Unlike many public companies that simply tout new deals without follow-through, VSee Health is proving its commitment by actively activating hospitals, scaling services, and driving real revenue growth from existing partnerships. This milestone underscores iDoc's role in revolutionizing healthcare delivery, ensuring patients receive top-tier remote care while boosting the company's bottom line.
Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner.
UniDoc Receives Order for Health Cubes
Three units for demonstration within Verizon Innovation Labs
As UnitedHealthcare Scales Back Traditional RPM, Addison(R) Virtual Caregiver Signals the Next Phase of Home-Based Care
Electronic Caregiver's 24/7 virtual caregiving platform steps forward just as payers move away from low-engagement, device-only monitoring.
Venezuela says US terrorist designation a 'ridiculous lie'
Venezuela on Monday rejected the US terrorist designation of an alleged drug cartel on its territory as a "ridiculous lie" aimed at paving the way for an "illegitimate" military intervention.
France allows drug trafficker day release from supermax prison
A prisoner convicted of drug trafficking and held in a French high-security jail was granted a day release on Monday to meet a potential employer, sparking controversy.
Mexico training ship that hit Brooklyn Bridge returns home
The Mexican naval training ship that crashed into the Brooklyn Bridge in May, leaving two crew members dead, returned home on Sunday to official fanfare in the port of Veracruz.
Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference
DENVER, CO / ACCESS Newswire / November 24, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced that its management will participate at NobleCon21 - Noble Capital Markets' 21st Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL.
Medical Care Technologies Inc. (OTC Pink:MDCE) Ranked #2 on InvestorsHub's Breakout Board as Subsidiaries Surpass $848,000 in Revenue and AI Technology Development Advances
"Subsidiaries deliver strong revenue performance as MDCE advances development of innovative AI-driven health and nutrition technologies."
Qatari-Owned Ameerex Corporation (OTC: HIRU) - First OTC-Listed U.S. Company Owned and Directly Managed by Qatari Investors Expanding Into Oil, Gas and Mineral Resources
Confirms Falcon Caddo Project in Texas Targeting 5,000 Barrels per Day
Legendary Graffiti Icon CES Unveils Explosive Interior Mural at Highlife Health, Cementing the Dispensary as New Rochelle's New Cultural Hub
A godfather of New York graffiti.
Jaguar Health Secures New Patent for Crofelemer in Short Bowel Syndrome, Strengthening Global IP Position Ahead of Additional Clinical Milestones
This new IP supports crofelemer's global exclusivity in rare pediatric intestinal failure coincident with published clinical data showing reductions in parenteral support requirements with crofelemer - supporting Jaguar's strategy to secure non-dilutive partnership fundingRecent publication by members of Jaguar's Scientific Advisory Board and other intestinal failure key opinion leaders: "Targeted Literature Review and Assessment of Evidence in Microvillus Inclusion Disease (MVID)"
Who is the Best Facelift Surgeon in the World?
The best facelift surgeon in the world is Dr. Santos.
What is the Best Online Botox Course?
The Best Online Botox Course is by the American Academy of Cosmetic Medicine™
Specificity Achieves Positive Operating Cash Flow for November
TAMPA, FLORIDA / ACCESS Newswire / November 24, 2025 / Specificity Inc. (OTCID:SPTY) (the "Company"), a disruptor in the digital marketing space, is pleased to announce that it reached a major milestone in reaching positive operating cash flow for the month of November.
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates
German Federal Cartel Office clearance obtained for the planned BioNTech - CureVac transaction announced on June 12, 2025, marking an important step toward the expected closing later this yearOffer period for BioNTech's public exchange offer for all outstanding CureVac N.V. shares began on October 21, 2025, and is scheduled to expire on December 3, 2025German litigation with Pfizer/BioNTech related to mRNA-based COVID-19 vaccines has been paused pending completion of BioNTech's public exchange offerReceived Clinical Trial Application (CTA) clearance from the European Medicines Agency (EMA) for CVHNLC squamous non-small cell lung cancer (sqNSCLC)CVGBM (glioblastoma) Phase 1 Part B remains on trackStrong cash and cash equivalents position of €416.1 million as of September 30, 2025, confirming expected cash runway into 2028CureVac received final audit report relating to the Advance Purchase Agreement with the European Commission for CureVac's first-generation COVID-19 vaccine candidate
AI/ML Subsidiary Neural Cloud Begins Pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care
Pilot Project to Explore AI-Driven ECG Signal Processing and Predictive Deterioration Models in Pediatric Cardiac Care
Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes
LAVAL, QC / ACCESS Newswire / November 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") today announced the commencement of offers to exchange the Company's outstanding 4.875% Senior Secured Notes due 2028 (the "4.875% Notes") and 11.00% Senior Secured Notes due 2028 (the "11.00% Notes" and together with the 4.875% Notes, the "Existing Senior Secured Notes") for up to $1.6 billion aggregate principal amount (the "Maximum Notes Amount") of new 10.00% Senior Secured Notes due 2032 (the "New Notes" and, such offers, the "Offers") issued by 1261229 B.C. Ltd., the Company's indirect wholly-owned subsidiary (the "Issuer" and, together with the Company, the "Offerors"), in each case, pursuant to the terms described in a confidential exchange offer memorandum dated November 24, 2025 (the "Exchange Offer Memorandum"). The New Notes will be treated as a single series with the Issuer's $4.4 billion principal amount of 10.00% Senior Secured Notes due 2032 (the "Existing Numberco Notes") that were issued in April 2025 and will be issued under the same indenture. Further, the New Notes are expected to have the same CUSIP numbers as (except that New Notes issued pursuant to Regulation S under the Securities Act of 1933, as amended (the "Securities Act") will trade separately under a different CUSIP number until at least 40 days after the issue date of the New Notes and thereafter, subject to the terms of the indenture and the applicable procedures of the depositary), and to be fungible for trading purposes with, the Existing NumberCo Notes. The Offers are scheduled to expire on December 23, 2025, unless extended in accordance with applicable laws and the terms of the Offers. The Company is conducting the Offers to manage its intermediate term debt maturities as permitted under its outstanding debt agreements.
Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESS Newswire / November 24, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, will be participating in an Analyst-Moderated fireside chat at the 37th Annual Piper Sandler Healthcare Conference on Wednesday, December 3rd, 2025, at 2:00 pm ET. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation.
Organto Foods Arranges New Financing and Foreign Exchange Facilities with Rabobank
VANCOUVER, BC / ACCESS Newswire / November 24, 2025 / Organto Foods Inc. (TSX-V:OGO)(OTCQXC:OGOFF)(FSE:OGF0) ("Organto" or the "Company"), an integrated provider of branded, organic, and value-added organic and fairtrade fruit and vegetable products, is pleased to announce that its European foods operations have entered into an integrated financial and foreign exchange solution with COÖPERATIEVE RABOBANK U.A. ("Rabobank"), based in the Netherlands.
Bolsonaro says ankle monitor tampering driven by 'paranoia'
Brazil's former president Jair Bolsonaro, detained after allegedly using a soldering iron on his court-ordered ankle monitor, argued Sunday that a state of "paranoia" had led him to tamper with the device.
What does US 'terrorist' designation for Venezuela mean?
Washington's designation of an alleged Venezuelan cartel as a foreign terrorist organization (FTO) takes effect on Monday, opening the door to new forms of US pressure on President Nicolas Maduro.
Myanmar junta says nearly 1,600 foreigners arrested in scam hub raids
Myanmar's military said Sunday it arrested nearly 1,600 foreign nationals in five days in a highly publicised crackdown on a notorious internet scam hub on the Thai border.